CorVel Corp. $CRVL Shares Sold by UBS Group AG

UBS Group AG decreased its position in CorVel Corp. (NASDAQ:CRVL) by 37.8% in the 4th quarter, HoldingsChannel reports. The firm owned 42,299 shares of the business services provider’s stock after selling 25,721 shares during the period. UBS Group AG’s holdings in CorVel were worth $2,862,000 at the end of the most recent reporting period.

Other institutional investors have also recently added to or reduced their stakes in the company. B. Metzler seel. Sohn & Co. AG purchased a new stake in CorVel in the 4th quarter valued at about $272,000. M&T Bank Corp grew its holdings in CorVel by 1,230.0% in the 4th quarter. M&T Bank Corp now owns 63,439 shares of the business services provider’s stock valued at $4,293,000 after buying an additional 58,669 shares during the period. Evergreen Capital Management LLC purchased a new stake in CorVel in the 4th quarter valued at about $784,000. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in CorVel by 29.2% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,770 shares of the business services provider’s stock valued at $526,000 after buying an additional 1,758 shares during the period. Finally, Eagle Bay Advisors LLC purchased a new stake in CorVel in the 4th quarter valued at about $37,000. Institutional investors and hedge funds own 51.36% of the company’s stock.

CorVel Price Performance

CRVL opened at $62.74 on Tuesday. The stock has a market capitalization of $3.21 billion, a price-to-earnings ratio of 29.32 and a beta of 0.98. The business has a 50-day moving average of $56.14 and a two-hundred day moving average of $61.57. CorVel Corp. has a 12 month low of $44.83 and a 12 month high of $114.42.

CorVel (NASDAQ:CRVL) last posted its quarterly earnings results on Tuesday, May 19th. The business services provider reported $0.61 EPS for the quarter. The company had revenue of $248.55 million during the quarter. CorVel had a return on equity of 29.92% and a net margin of 11.51%.

Insider Buying and Selling

In other news, insider Maxim Shishin sold 2,400 shares of the business’s stock in a transaction dated Monday, March 16th. The stock was sold at an average price of $54.00, for a total transaction of $129,600.00. Following the completion of the sale, the insider owned 7,050 shares in the company, valued at approximately $380,700. The trade was a 25.40% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 44.56% of the stock is owned by company insiders.

Analyst Ratings Changes

Separately, Weiss Ratings cut CorVel from a “hold (c-)” rating to a “sell (d+)” rating in a report on Monday, April 6th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, the company has a consensus rating of “Sell”.

CorVel Company Profile

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).